BRIEF-Aurinia releases open-label AURION data for Voclosporin
Oct 6 (Reuters) - Aurinia Pharmaceuticals Inc :
* Label AURION data demonstrating increased remission rates over time for Voclosporin in the treatment of Lupus Nephritis
* Complete remission rates increase to 70 pct in open-label study at 24 weeks
* Patients in remission at eight weeks remained in remission at 24 weeks Source text for Eikon: Further company coverage:
© Thomson Reuters 2017 All rights reserved.